FASN and lung cancer: It upregulates the expression of lipogenic enzymes, such as fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACACA), thus enhancing de novo lipogenesis, resulting in increased lipid droplet formation within lung cancer cells [36].